In the elite world of Dividend Aristocrats – those S&P 500 members that have consistently raised their dividend payouts for at least 25 years – one name is shaking things up this quarter. Kenvue Inc. (KVUE), the healthcare giant that spun off from Johnson & Johnson's (JNJ) consumer division last year, made a splash with its latest earnings report.
Last month, KVUE also boosted its dividend, and its yield now outshines those of both the S&P 500 Dividend Aristocrats ETF (NOBL) and S&P 500 SPDR (SPY), turning heads among passive income investors. And following a Q2 earnings report that crushed expectations on both the top and bottom lines, KVUE stock shot up double digits on Aug. 6 for its biggest daily gain on record.
